Correlation Between Day One and Merus BV

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Day One and Merus BV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Merus BV into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Merus BV, you can compare the effects of market volatilities on Day One and Merus BV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Merus BV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Merus BV.

Diversification Opportunities for Day One and Merus BV

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Day and Merus is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Merus BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Merus BV and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Merus BV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Merus BV has no effect on the direction of Day One i.e., Day One and Merus BV go up and down completely randomly.

Pair Corralation between Day One and Merus BV

Given the investment horizon of 90 days Day One is expected to generate 2.18 times less return on investment than Merus BV. But when comparing it to its historical volatility, Day One Biopharmaceuticals is 1.03 times less risky than Merus BV. It trades about 0.03 of its potential returns per unit of risk. Merus BV is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  2,673  in Merus BV on August 28, 2024 and sell it today you would earn a total of  1,866  from holding Merus BV or generate 69.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Day One Biopharmaceuticals  vs.  Merus BV

 Performance 
       Timeline  
Day One Biopharmaceu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Merus BV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merus BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Day One and Merus BV Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Day One and Merus BV

The main advantage of trading using opposite Day One and Merus BV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Merus BV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Merus BV will offset losses from the drop in Merus BV's long position.
The idea behind Day One Biopharmaceuticals and Merus BV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing